Lidocaine/Allantoin/Glycyrrhetinic Acid/Vitamin E

利多卡因/尿囊素/甘草次酸/维生素E

Report date: 2026/02/13 10:40:17

Base Information

Drug NameLidocaine/Allantoin/Glycyrrhetinic Acid/Vitamin E
Drug Alias Name复方卡因次酸一维栓
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit modulatorsCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsSodium channel alpha subunitCorticosteroid 11-beta-dehydrogenase isozyme 1Pregnane X receptor
Therapy Area/IndicationsPainHemorrhoidsFissure in Ano +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes LidocaineAllantoinGlycyrrhetinic Acid
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHuadong Medicine Co LtdHuadong Medicine (Xi'An) Bodyguard Pharmaceutical Co LtdJiu Tai Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsPainHemorrhoidsFissure in Ano +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A